Katten Muchin Rosenman LLP assisted eTrueNorth with a public-private partnership between the US Department of Health and Human Services (HHS).
eTrueNorth, the U.S.-based healthcare technology company that enables laboratory testing at retail pharmacies, is enabling new drive-through COVID-19 testing sites that are opening daily in partnership with a growing list of national pharmacy chains that include Walmart, The Kroger Co., and McKesson’s Health Mart.
Work to begin this public-private partnership began on March 13 and includes funding by the U.S. Department of Health and Human Services (HHS). Just over 45 days from its beginning, the public-private partnership is opening new parking lot sites in towns and cities across the nation daily. eTrueNorth’s goal is to actively participate in hundreds of testing sites across the country.
eTrueNorth has established a network of more than 7,500 local pharmacies across the nation which are certified as CLIA-waived laboratories and have empowered pharmacists to expand their role in the delivery of health services to their customers.
In October 2018, the company announced the launch of a technology infrastructure platform to issue vouchers to individuals who need clinical testing. When the COVID-19 pandemic hit, eTrueNorth utilized its proven technology to aid with drive-through testing.
eTrueNorth drives access, quality, and affordability by enabling healthcare services to be provided to consumers at local pharmacies. By empowering local pharmacists to administer preventative healthcare screenings and close gaps in care, eTrueNorth works in partnership with retail pharmacies, self-funded employers, third-party payors and pharmaceutical manufacturers to identify undiagnosed conditions and better manage chronic diseases.
The Katten team included Kenya S. Woodruff (Picture), Lisa Prather and Bernard Miller.